By activating GLP-1 receptors, semaglutide helps: Stimulate insulin production when blood sugar is high Reduce glucagon secretion, which further lowers blood sugar Slow down digestion, promoting a feeling of fullness Decrease appetite by acting on brain centers controlling hunger The FDA has approved Ozempic for the treatment of type 2 diabetes, while Wegovy, a higher-dose formulation of semaglutide, is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Direct Meds is a LegitScript-certified telehealth platform that connects patients with licensed healthcare providers for GLP-1 weight loss prescription evaluation
Understanding the distinction between these medications, their approved uses, and the regulatory landscape is vital for patient safety and effective treatment
Our program uses a low-dose, gradual microdosing approach
Look for any floating specks, fibers, or sediment